# A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas

> **NCT02456324** · PHASE2 · UNKNOWN · sponsor: **Curaseal Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Anal Fistulas
- Rectal Fistulas

## Interventions

- **DEVICE:** PICS-AF Device
- **DEVICE:** Historical Controls Treated with Commercially Available Fistula Plugs

## Key facts

- **NCT ID:** NCT02456324
- **Lead sponsor:** Curaseal Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456324, "A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02456324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*